Physician
Dayton Vitreo-Retinal Associates, INC.
Dayton Vitreo-Retinal Associates, INC. was paid $1.63M by Medicaid between Jan 2018 and Nov 2024, across 20 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 56% of everything it billed.
33Billing provider infoDAYTON VITREO-RETINAL ASSOCIATES, INC.
DAYTON, OH 45402
DAYTON, OH 45402
33aNPI1881792679assigned 09/20/2006
33bProvider typeOphthalmology Physician
28Total paid$1.63M
24GClaims25,222
24DCodes billed20
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in Ohio
Rank by total paid#6 of 155
Median peer was paid$10K
This provider vs. median156×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,169 | $170K | |
| 2019 | 3,906 | $150K | |
| 2020 | 3,052 | $145K | |
| 2021 | 4,647 | $436K | |
| 2022 | 4,562 | $449K | |
| 2023 | 3,166 | $191K | |
| 2024incomplete | 1,720 | $88K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 56% | 1,010 | 643 | $911K |
| 67028 | Intravitreal injection of a pharmacologic agent | 19% | 5,376 | 4,202 | $317K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.7% | 4,396 | 3,668 | $125K |
| 92134 | 6.7% | 9,465 | 7,795 | $109K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.0% | 1,070 | 930 | $49K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.0% | 558 | 480 | $33K |
| 67228 | 1.2% | 62 | 44 | $20K | |
| J9035 | Injection, bevacizumab, 10 mg | 1.2% | 507 | 409 | $20K |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 1.1% | 15 | 12 | $17K |
| J3490 | Unclassified drugs | <1% | 268 | 203 | $15K |
| 92235 | <1% | 278 | 242 | $10K | |
| 92225 | <1% | 64 | 38 | $842.75 |
8 more codes
| G8482 | Influenza immunization administered or previously received | 0% | 189 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 613 | $0.00 |
| 4040F | 0% | 548 | $0.00 | |
| 2026F | 0% | 30 | $0.00 | |
| 2024F | 0% | 30 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 322 | $0.00 |
| 1036F | 0% | 403 | $0.00 | |
| 99024 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMILLER, STEVEN (PARTNER)
| Provider | Location | Paid |
|---|---|---|
| Long Island Center for Child Develoment | Cedarhurst, NY | $4.53M |
| North Star Transit Corp | Bloomington, MN | $3.43M |
| Miller Medi-Van, INC. | Minneapolis, MN | $337K |
| S. Troy Miller, DDS, Opelousas, Apdc | Opelousas, LA | $229K |
| Visionaries LLC | Hutchinson, KS | $68K |
| Newton Wellesley Radiology Assoc | Newton, MA | $39K |
| Millers Helping Hand Medical Transportation LLC | Walker, LA | $27K |
| South Vermillion Community School Corporation | Clinton, IN | $15K |
| Unity Eye Centers INC | Norfolk, NE | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.